MI
CERO

MMCAP International’s CERo Therapeutics CERO Stock Holding History

MMCAP International’s Portfolio CERO Stock Details CERO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-185
Closed -$3.8M – 275
2022
Q4 		$3.8M Hold
185
– – 0.38% 91
2022
Q3 		$3.73M Hold
185
– – 0.3% 130
2022
Q2 		$3.71M Sell
185
-190
-51% -$3.81M 0.3% 134
2022
Q1 		$7.5M Buy
375
+250
+200% +$4.97M 0.44% 74
2021
Q4 		$2.48M Buy
+125
New +$2.48M 0.15% 209

Other funds holding CERO

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 18.84% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

MMCAP International's CERO Position: Q1 2023 in Review

MMCAP International sold out of CERo Therapeutics (CERO) in Q1 2023, closing a stake of 185 shares — an estimated $3.8M sold.

MMCAP International first reported a position in CERO in Q4 2021 and held it in 5 quarters. The position peaked at $7.5M in Q1 2022. 15 funds tracked by Wall St. Rank hold CERO as of Q1 2023.

  • MMCAP International reported no remaining CERo Therapeutics position as of Q1 2023 after selling out during the quarter.
  • MMCAP International sold 185 CERo Therapeutics shares in Q1 2023, an estimated $3.8M.
  • MMCAP International first reported a position in CERo Therapeutics in Q4 2021 and held it in 5 quarters.
  • MMCAP International's CERo Therapeutics position peaked at $7.5M in Q1 2022.
  • 15 funds tracked by Wall St. Rank held CERo Therapeutics as of Q1 2023.

Based on MMCAP International's 13F filing for Q1 2023, filed 11 May 2023.